Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-10 Sale | 2023-02-14 7:16 pm | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 4,500 | $10 | $45,005 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-06-23 4:16 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Hoitt Jason Chief Patient Officer | 0 | $0 | 521,802 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 9:10 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-12-08 Option Award | 2022-12-09 8:31 pm | 2022-12-08 2030-01-07 | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 140,663 | $0 | 415,763 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:20 pm | N/A 2032-01-18 | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 145,000 | $0 | 145,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-14 7:39 pm | N/A 2031-05-12 | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 139,500 | $0 | 139,500 (Direct) | View |
| 2020-07-15 Option Award | 2020-07-16 6:01 pm | N/A 2030-07-15 | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 137,750 | $0 | 137,750 (Direct) | View |